COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020.

Saved in:
Bibliographic Details
Title: COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020.
Authors: Acosta AM; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mathis AL; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; All Native Synergies Company, Winnebago, Nebraska, USA., Budnitz DS; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; US Public Health Service, Rockville, Maryland, USA., Geller AI; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; US Public Health Service, Rockville, Maryland, USA., Chai SJ; US Public Health Service, Rockville, Maryland, USA.; California Emerging Infections Program, Oakland, California, USA.; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Alden NB; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Anderson EJ; Emory University School of Medicine, Atlanta, Georgia, USA.; Georgia Emerging Infections Program, Atlanta, Georgia, USA.; Veterans Affairs Medical Center, Atlanta, Georgia, USA., Ryan P; Maryland Department of Health, Baltimore, Maryland, USA., Kim S; Michigan Department of Health and Human Services, Lansing, Michigan, USA., Como-Sabetti K; Minnesota Department of Health, St. Paul, Minnesota, USA., Torres S; New Mexico Department of Health, Santa Fe, New Mexico, USA., Dufort E; New York State Department of Health, Albany, New York, USA., Bennett NM; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Billing LM; Ohio Department of Health, Columbus, Ohio, USA., Sutton M; Oregon Health Authority, Portland, Oregon, USA., Keipp Talbot H; Vanderbilt University Medical Center, Nashville, Tennessee, USA., George A; Salt Lake County Health Department, Salt Lake City, Utah, USA., Pham H; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Hall AJ; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Fry A; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; US Public Health Service, Rockville, Maryland, USA., Garg S; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; US Public Health Service, Rockville, Maryland, USA., Kim L; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; US Public Health Service, Rockville, Maryland, USA.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2020 Nov 09; Vol. 7 (11), pp. ofaa528. Date of Electronic Publication: 2020 Nov 09 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2328-8957
DOI:10.1093/ofid/ofaa528